NCT06825715

Brief Summary

The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,653

participants targeted

Target at P75+ for not_applicable

Timeline
47mo left

Started Jul 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jul 2025Feb 2030

First Submitted

Initial submission to the registry

February 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

July 2, 2025

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2030

Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

3.7 years

First QC Date

February 7, 2025

Last Update Submit

July 31, 2025

Conditions

Advanced Cancers of the ProstateCancers of the Lung

Outcome Measures

Primary Outcomes (1)

  • Use of molecular testing

    Proportion of eligible patients with lung and prostate cancer who have next generation sequencing molecular testing

    3 years

Secondary Outcomes (1)

  • Use of targeted therapy

    3 years

Study Arms (1)

During intervention period

EXPERIMENTAL

All sites will receive the 3 level intervention of patient education, provider audit/feedback, and EMR order change.

Other: Multilevel intervention

Interventions

Multilevel interventionOTHER

3 components: patient education video, provider audit/feedback, and EMR ordering change

During intervention period

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients in the VA with cancer of the lung or prostate who are seen in the oncology clinic

You may not qualify if:

  • Cancer that did not originate in the prostate or the lung

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA NY Harbor Healthcare System, New York, NY

New York, New York, 10010-5011, United States

RECRUITING

Study Officials

  • Daniel J Becker, MD

    VA NY Harbor Healthcare System, New York, NY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antoinette Vo, BA MA

CONTACT

(212) 686-7500antoinette.vo@va.gov

Daniel J Becker, MD

CONTACT

(212) 686-7500Daniel.Becker2@va.gov

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Multilevel intervention with components of patient education, provider audit/feedback, and change in electronic medical record test order and results return.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2025

First Posted

February 13, 2025

Study Start

July 2, 2025

Primary Completion (Estimated)

February 28, 2029

Study Completion (Estimated)

February 28, 2030

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations

US(1)